Chicago Business

Chicago Business

AbbVie's potential $713M drug deal

AbbVie's potential 3M drug deal

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Wednesday, February 28, 2024

Unlock access to this breaking news and much more with a Health Pulse subscription.

Outside an AbbVie building in Waukegan

AbbVie, still adding to its pipeline, enters drug deal potentially worth $713 million

The pharmaceutical giant is collaborating with a French immunotherapy company working on a new approach to treating autoimmune diseases.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

<![if !mso]> <![endif]>

VIEW OUR SUBSCRIPTION OFFERS

This email was sent to chicagobusinessus627@emails.newslettersbase.com
Manage My Account | Contact Us

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

This email was sent

February 28, 2024 4:33pm
Country:

United States
Tags